VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 56 filers reported holding VERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $220,183 | -14.6% | 16,060 | 0.0% | 0.28% | -23.1% |
| Q2 2023 | $257,763 | +106.8% | 16,060 | 0.0% | 0.36% | +337.3% |
| Q1 2023 | $124,626 | -59.9% | 16,060 | 0.0% | 0.08% | -51.2% |
| Q4 2022 | $310,761 | -9.1% | 16,060 | 0.0% | 0.17% | -11.0% |
| Q3 2022 | $342,000 | +56.2% | 16,060 | 0.0% | 0.19% | +73.6% |
| Q2 2022 | $219,000 | -41.9% | 16,060 | 0.0% | 0.11% | -30.4% |
| Q1 2022 | $377,000 | -56.1% | 16,060 | -50.0% | 0.16% | -53.9% |
| Q4 2021 | $858,000 | – | 32,120 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $87,472,500 | 9.83% |
| Kynam Capital Management, LP | 3,000,000 | $48,150,000 | 6.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 975,227 | $15,642,641 | 4.76% |
| Sofinnova Investments, Inc. | 3,467,156 | $55,647,854 | 3.64% |
| Eversept Partners, LP | 1,740,951 | $27,942,264 | 2.34% |
| Altium Capital Management LP | 120,000 | $1,926,000 | 1.46% |
| Carlyle Group Inc. | 2,416,837 | $38,766,065 | 1.38% |
| SECTORAL ASSET MANAGEMENT INC | 351,646 | $5,643,918 | 0.94% |
| Tri Locum Partners LP | 108,928 | $1,748,294 | 0.65% |
| Orbimed Advisors | 1,756,800 | $28,196,640 | 0.51% |